Vertiyo Creative Services Launches Pharma Division
NEW YORK (October 27, 2009) – Vertiyo Creative Group<http://www.vertiyo.com/> Inc., a full-service branding and marketing agency based in New York City, today announced the launch of Vertiyo Health, a new division focused on pharmaceutical marketing. Vertiyo Health will be headed by John DeFranco, an industry veteran with more than 25 years of pharmaceutical marketing experience. The new unit offers pharma clients a cost-effective alternative to larger ad agencies, while providing marketing services across a wide range of outlets including print, online and social media. For more information on the group’s industry experience and capabilities, visit www.vertiyohealth.com.
DeFranco began his career in pharmaceutical sales as a field representative, hospital rep and hospital field trainer for Beecham Labs. He later became a product manager for the company with responsibility for injectable antibiotics, and oversaw the launch of Timentin, the first injectable beta-lactamase inhibitor.
DeFranco’s medical advertising experience includes work on major U. S. brands including Pipracil, Prozac, Zerit, Invirace and Zyrtec. He has also supervised the launch of many global brands, including Zyprexa, Synercid, Xenical, Xolair and Pristiq. He can be reached at firstname.lastname@example.org
“Our size makes us nimble enough to react to our clients in a way that larger agencies often can’t,” said DeFranco. “We're also able to put new ideas and innovative social strategies in front of our clients much more quickly and efficiently."
Vertiyo Creative Group founder Marc Scibelli (email@example.com
Agency offices are located at 17 Battery Place, Suite 906, New York, NY 10004/ (917) 832-1531.
Vertiyo Creative Group is a full-service agency that delivers superior client performance based on creative curiosity. Part ad agency, part digital think tank, Vertiyo Creative Group is pioneering a new agency-client partnership model through innovations such as risk-sharing cooperatives and creation of proprietary digital products. To learn more, visit www.vertiyo.com<http://www.vertiyo.com/>.
# # #
Contact: Lee Feldman, Peters & Feldman for Vertiyo Phone: (203) 341-8922 E-mail: firstname.lastname@example.org
Posted: October 2009